Literature DB >> 30138104

Cold atmospheric plasma is a viable solution for treating orthopedic infection: a review.

Ly Nguyen1, Peng Lu2, Daniela Boehm2, Paula Bourke2, Brendan F Gilmore3, Noreen J Hickok1, Theresa A Freeman1.   

Abstract

Bacterial infection and antibiotic resistance are major threats to human health and very few solutions are available to combat this eventuality. A growing number of studies indicate that cold (non-thermal) plasma treatment can be used to prevent or eliminate infection from bacteria, bacterial biofilms, fungi and viruses. Mechanistically, a cold plasma discharge is composed of high-energy electrons that generate short-lived reactive oxygen and nitrogen species which further react to form more stable compounds (NO2, H2O2, NH2Cl and others) depending on the gas mixture and plasma parameters. Cold plasma devices are being developed for medical applications including infection, cancer, plastic surgery applications and more. Thus, in this review we explore the potential utility of cold plasma as a non-antibiotic approach for treating post-surgical orthopedic infections.

Entities:  

Keywords:  Staphylococcus aureus; bacteria; biofilm; cold plasma; orthopedic infection; titanium

Mesh:

Substances:

Year:  2018        PMID: 30138104     DOI: 10.1515/hsz-2018-0235

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   4.700


  2 in total

1.  The beneficial effect of cold atmospheric plasma on parameters of molecules and cell function involved in wound healing in human osteoblast-like cells in vitro.

Authors:  B Eggers; J Marciniak; S Memmert; F J Kramer; J Deschner; M Nokhbehsaim
Journal:  Odontology       Date:  2020-02-06       Impact factor: 2.634

Review 2.  Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology.

Authors:  Pavol Zubor; Yun Wang; Alena Liskova; Marek Samec; Lenka Koklesova; Zuzana Dankova; Anne Dørum; Karol Kajo; Dana Dvorska; Vincent Lucansky; Bibiana Malicherova; Ivana Kasubova; Jan Bujnak; Milos Mlyncek; Carlos Alberto Dussan; Peter Kubatka; Dietrich Büsselberg; Olga Golubnitschaja
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.